660 results about "Chromatography" patented technology

The present invention provides a process for the production of erythropoietin (EPO) with high purity and with a desired profile of EPO glycol-isoforms by using a combination of specific chromatographic steps in such a manner that the starting EPO glycol-isoform profile is changed or modified. The applied chromatographic steps includes at least (a) dye affinity chromatography, and (b) hydrophobic chromatography and/or (c) anion-exchange chromatography. In a preferred embodiment, the process further includes (d) gel filtration chromatography. The present invention also provides a process for the determination of erythropoietin (EPO) glycol-isoform profile in an EPO containing composition.

The invention provides a high throughput, high purity, high yield system and method of isolating and purifying rebaudioside A (“Reb A”), with acceptable water solubility for all commercial uses, from commercially available Stevia rebaudiana starting material. The invention also provides a means of maximizing yields of 99+% purity Reb A based on the attributes of a given batch of Stevia starting material. The Reb A produced by the invention is water soluble, devoid of bitterness heretofore associated with rebaudioside sweeteners, non-caloric, and suitable for use as a reagent and as an ingredient in orally consumed products, e.g., as a sweetener, flavor enhancer, and flavor modifier.

The gaseous effluent flowing in through line 1 is contacted in absorption zone ZA with the liquid absorbent solution flowing in through line 9. The gaseous effluent depleted in acid compounds is discharged through line 2. The absorbent solution laden with acid compounds is discharged through line 3. The absorbent solution once laden with acid compounds comprises two phases: a first phase poor in acid compounds and a second phase rich in acid compounds. The two phases are separated in zone ZS. The first phase is recycled through lines 5 and 9 to absorption zone ZA. The second phase is fed through line 4 into regeneration zone ZR. In zone ZR, the acid compounds are separated from the absorbent solution. The acid compounds are discharged through line 7. The regenerated absorbent solution is recycled through lines 6 and 9 to zone ZA.

A suspension formulation for therapeutic use includes a non-aqueous, hydrophobic vehicle exhibiting viscous fluid characteristics, a dry particle formulation comprising a biomolecule dispersed in the vehicle, and a surfactant incorporated in at least one of the vehicle and dry particle formulation. A dry particle formulation includes an interferon, a buffer, a surfactant, and one or more stabilizers selected from the group consisting of a carbohydrate, an antioxidant, and an amino acid.

The present invention relates to a method of removing a biofilm, which comprises at least the following steps, carried out simultaneously or consecutively: a) a solution comprising an enzyme mixture containing at least one enzyme chosen from the group of proteases, at least one enzyme chosen from the group of esterases and an amylase is prepared; b) a solution comprising a detergent with an alkaline pH is prepared; and c) said solutions are applied, by washing or by circulation, to the surface to be treated. It also relates to a kit intended for removing a biofilm, which comprises the solutions defined above and the compositions comprising the said solutions.

Provided is a microfluidic device suitable for analyzing a liquid sample. The device includes a first chamber to contain a sample; a second chamber to contain a liquid first reagent; a third chamber containing a lyophilized second reagent; a plurality of channels connecting the first, second, and third chambers.

Disclosed is a lateral flow assay device to test for the presence and/or amount of a nucleic acid sequence of interest in a sample, the lateral flow device comprising: (a) a sample receiving zone for contacting the device with a sample to be tested; (b) an extraction zone (8) for extraction of nucleic acid from the sample; (c) a nucleic acid amplification zone (18) in liquid communication with the sample receiving zone; and (d) a detection zone (20) for detecting the products, directly or indirectly, of a nucleic acid amplification reaction performed in the nucleic acid amplification zone, said detection zone (20) being, or being locatable, in liquid communication with the amplification zone (18).

A solvent that reversibly converts from a nonionic liquid mixture to an ionic liquid upon contact with a selected trigger, e.g., contact with CO₂, is described. In preferred embodiments, the ionic solvent is readily converted back to the nonionic liquid mixture. The nonionic liquid mixture includes an amidine or guanidine or both, and water, alcohol, or a combination thereof. Single component amine solvents that reversibly convert between ionic and non-ionic states are also described. Some embodiments require increased pressure to convert; others convert at 1 atmosphere.

The invention provides an oilfield suspending friction reducer treatment composition fluid comprising from about 0.001 weight percent to about 0.5 weight percent of a drag reducing surfactant; at least one drag reducing enhancer selected from the group consisting of polymeric drag reduction enhancers, monomeric drag reduction enhancers, and mixtures thereof.

A carbon dioxide separation system comprises a first flow path for directing a fluid comprising carbon dioxide therethrough, a second flow path for directing a sweep fluid therethrough, and a separator comprising a material with selective permeability of carbon dioxide for separating the first and the second flow paths and for promoting carbon dioxide transport therebetween. A carbon dioxide separation unit is in fluid communication with the second flow path for separating the transported carbon dioxide from the sweep fluid.

An optically clear, pharmaceutically acceptable aqueous composition comprising paclitaxel or a derivative thereof, serum albumin and a pharmaceutically acceptable vehicle, wherein the composition comprises no more than 10% organic solvent and has a pH of about 3.0 to about 4.8, is described. The serum albumin can be fatted or defatted, and the composition can optionally be lyophilized or optionally lyophilized and reconstituted. At least 70% of the paclitaxel is bound to serum albumin, the ratio of paclitaxel to albumin is at least about 1:5, and the concentration of paclitaxel is at least about 25 μg/ml. Methods of making and using this composition an also provided.

Devices, processes, and kits for the extraction of nucleic acids from biological samples are disclosed. The devices comprise a first port, a second port, and a binding chamber intermediate and in fluid communication with the first port and the second port. The binding chamber comprises an unmodified flat glass surface effective for binding a heterogeneous population of nucleic acids. The first port, second port, and binding chamber define a continuous fluid pathway that is essentially free of nucleic acid-specific binding sites.

Ultraporous sol gel monoliths and methods for preparing the same are provided, having superior flow characteristics for chromatography and analytical chemistry applications. The methods for forming an ultra porous sol-gel monolith include (a) forming a solution comprising a porogen, a matrix dissolving catalyst and a sol gel precursor; (b) allowing the solution to form a gel; and (c) drying the gel at an elevated temperature. The ultraporous sol gel monoliths are characterized by a porosity of up to about 97%, a BET surface area of at least about 50 m²/g and substantially no micropores.

A post-CMP cleaning composition and method comprising same are disclosed herein. In one aspect, there is provided a composition comprising: water, an organic base, and a plurality of chelating agents comprised of a poly-amino carboxylic acid and a hydroxylcarboxylic acid wherein the pH of the composition ranges from 9.5 to 11.5.

An oil-in-water emulsion composition for wet-wipes delivering a particulate skin health benefit ingredient in the oil phase. A process for making an oil-in-water emulsion composition in which the oil phase is first made as a concentrate and then diluted in water.

The present invention relates to high flavor load particles and to methods of preparing same. The invention also relates to methods of using such particles to flavor tobacco products, including cigarettes and other conventional smoking articles.

An adsorbent for separating nitrogen from a mixed gas of oxygen and nitrogen is MSC wherein an oxygen and nitrogen separation ratio α and a ratio (t₉₅/t₅₀) of a time t₅₀ required for adsorbing 50% of the oxygen equilibrium adsorption amount and a time t₉₅ required for adsorbing 95% of the oxygen equilibrium adsorption amount satisfy the inequality

(t₉₅/t₅₀)<0.4×(α−24)α≧35.

The amount of adsorbent used with respect to a predetermined amount of nitrogen generated can be reduced since a method is carried out which uses this adsorbent to produce nitrogen by separating nitrogen from the mixed gas of oxygen and nitrogen by means of a PSA method. By this method, it is possible to reduce the cost of the apparatus and reduce and miniaturize the scale of the apparatus, and the power consumption amount can be reduced.

The present invention relates to a rinse-off antimicrobial cleansing composition comprising from about 0.001% to about 5% of an antimicrobial active, from about 1% to about 80% of an anionic surfactant, from about 0.1% to about 12% of a proton donating agent; from about 0.1% to about 30% of a deposition aid; and from about 3% to about 98.8% of water, wherein the composition is adjusted to a pH of from about 3.0 to about 6.0, wherein the rinse-off antimicrobial cleansing composition has a Gram Negative Residual Effectiveness Index of greater than about 0.3, and wherein the rinse-off antimicrobial cleansing composition has a Mildness Index of greater than 0.3. The invention also encompasses methods for cleansing skin and providing residual effectiveness versus Gram negative bacteria using these products.

Provided is an inexpensive and efficient saccharification method for woody biomass and a method of producing ethanol from woody biomass. A method for saccharification of woody biomass comprising hydrolysis treatment and an enzymatic treatment, in which a pretreatment process is performed prior to the enzymatic treatment and said pretreatment includes the steps of: hydrolyzing woody biomass, separating the resultant reaction product into a primary sugar solution and a residue, mixing the residue with an aqueous alkaline solution, and mixing with an oxidant capable of generating active oxygen.

The present invention relates to a multi-phase cosmetic composition for application to the body, which has a liquid and transparent appearance, becomes a homogeneous mixture after being stirred, the phases raps idly separating when at rest. The composition according to the present invention comprises at least one oily phase and at least one aqueous phase, further comprising a polyol, the oily phase comprising a mixture of at least one mineral oil and at least one vegetable oil, and the aqueous phase comprising a water-soluble salt.